JP6089163B1 - Beauty composition - Google Patents
Beauty composition Download PDFInfo
- Publication number
- JP6089163B1 JP6089163B1 JP2015229214A JP2015229214A JP6089163B1 JP 6089163 B1 JP6089163 B1 JP 6089163B1 JP 2015229214 A JP2015229214 A JP 2015229214A JP 2015229214 A JP2015229214 A JP 2015229214A JP 6089163 B1 JP6089163 B1 JP 6089163B1
- Authority
- JP
- Japan
- Prior art keywords
- hyaluronic acid
- ceramide
- composition
- skin
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title abstract description 51
- 230000003796 beauty Effects 0.000 title description 3
- 229940106189 ceramide Drugs 0.000 claims abstract description 63
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 62
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 62
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 62
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 58
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 58
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 58
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 56
- 230000015572 biosynthetic process Effects 0.000 claims description 19
- 238000003786 synthesis reaction Methods 0.000 claims description 18
- 239000002537 cosmetic Substances 0.000 abstract description 15
- 230000003020 moisturizing effect Effects 0.000 abstract description 9
- 230000005068 transpiration Effects 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 6
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 6
- 235000009566 rice Nutrition 0.000 abstract description 6
- 244000005700 microbiome Species 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 3
- 206010013786 Dry skin Diseases 0.000 abstract description 2
- 241000287828 Gallus gallus Species 0.000 abstract description 2
- 230000001629 suppression Effects 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 description 28
- 210000003491 skin Anatomy 0.000 description 24
- 101150027313 Has2 gene Proteins 0.000 description 20
- 210000004209 hair Anatomy 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 11
- 101710128038 Hyaluronan synthase Proteins 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 241000209094 Oryza Species 0.000 description 5
- 150000001783 ceramides Chemical class 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000118 hair dye Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 2
- -1 acidulants Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 125000001549 ceramide group Chemical group 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- 102100021407 ATP-dependent RNA helicase DDX18 Human genes 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Chemical group O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 101001041703 Homo sapiens ATP-dependent RNA helicase DDX18 Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical group O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical group 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000002305 glucosylceramides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
【課題】美容用、皮膚乾燥予防・改善用、皮膚水分蒸散抑制用、皮膚保湿用として有用な組成物の提供。【解決手段】セラミド及びヒアルロン酸を含有する組成物。該セラミドとしては、植物由来のセラミドであることが好ましく、米由来のセラミドであることが特に好ましい。該ヒアルロン酸は、鶏冠から得られたものであってもよく、また微生物由来のものであってもよい。該組成物は、経皮や経口等目的に応じて、適宜摂取することができる。【選択図】なし[PROBLEMS] To provide a composition useful for cosmetics, skin dry prevention / improvement, skin moisture transpiration suppression, and skin moisturizing. A composition containing ceramide and hyaluronic acid. The ceramide is preferably a plant-derived ceramide, and particularly preferably a rice-derived ceramide. The hyaluronic acid may be obtained from chicken crowns or may be derived from microorganisms. The composition can be taken as appropriate according to the purpose such as transdermal or oral. [Selection figure] None
Description
本発明は、美容組成物、皮膚乾燥予防・改善組成物、皮膚水分蒸散抑制組成物、皮膚保湿組成物に関する。 The present invention relates to a cosmetic composition, a skin dryness prevention / improving composition, a skin moisture transpiration inhibiting composition, and a skin moisturizing composition.
セラミドは、表皮の中でも、最も外側に位置する角質層における角質間細胞脂質の主要成分である。具体的には、セラミドは、皮膚の最外層を覆う角層細胞間脂質の主成分として特異的に存在し、皮膚本来が持つ生体と外界とのバリア膜としての機能維持に重要な役割を果たしている。角層の構造はレンガとモルタルに例えられ、約15層の積み重なった角層細胞を細胞間脂質が繋ぎ止める形で強固なバリア膜を形成している。角質細胞間脂質は、約50%のセラミドを主成分とし、コレステロール、脂肪酸等の両親媒性脂質から構成されており、疎水性部分と親水性部分が交互に繰り返される層板構造、いわゆるラメラ構造を特徴としている。 Ceramide is a major component of interstitial cell lipids in the outermost stratum corneum in the epidermis. Specifically, ceramide exists specifically as the main component of the stratum corneum intercellular lipid that covers the outermost layer of the skin, and plays an important role in maintaining the function of the skin as a barrier film between the living body and the outside world. Yes. The stratum corneum structure is compared to brick and mortar, and a strong barrier membrane is formed in such a way that intercellular lipids connect about 15 layers of stacked stratum corneum cells. The stratum corneum lipids are composed of approximately 50% ceramide as the main component and are composed of amphipathic lipids such as cholesterol and fatty acids. The so-called lamellar structure in which hydrophobic and hydrophilic portions are alternately repeated. It is characterized by.
セラミドは、例えば、蒟蒻芋由来のグルコシルセラミドを含有する表皮細胞増殖促進剤及び皮膚外用剤(特許文献1)、セラミド又はその誘導体を含有する抗アレルギー剤(特許文献2)等として利用できることが知られている。 It is known that ceramide can be used, for example, as an epidermal cell growth promoter and dermal external preparation (Patent Document 1) containing glucosylceramide derived from sputum, and an antiallergic agent (Patent Document 2) containing ceramide or a derivative thereof. It has been.
一方、ヒアルロン酸は、皮膚における表皮及び真皮、軟骨、関節液などに存在する高分子多糖類であり、組織内にゼリー状のマトリックスを形成することに基づく細胞の保持、組織の潤滑性と柔軟性の保持などの機能を有している。 Hyaluronic acid, on the other hand, is a high-molecular polysaccharide present in the epidermis and dermis, cartilage, joint fluid, etc. in the skin. It retains cells based on the formation of a jelly-like matrix in the tissue, and lubricates and softens the tissue. It has functions such as sex retention.
生体内におけるヒアルロン酸の量は、ストレス、紫外線、加齢等により減少する。皮膚中のヒアルロン酸の減少は、皮膚のハリの衰え、弾性の低下、皺など、皮膚の不調の原因となるほか、関節の機能異常等に関係することが知られている。ヒアルロン酸が減少する直接的な原因としては、ヒアルロニダーゼ(ヒアルロン酸分解酵素)や紫外線によるヒアルロン酸の分解、生体内のヒアルロン酸の産生量の減少が挙げられる。このため、皮膚の不調や関節の異常等の症状の予防、抑制、改善又は正常化のためには、生体内におけるヒアルロン酸量の減少抑制、又は、ヒアルロン酸の補填が必要である。 The amount of hyaluronic acid in a living body decreases due to stress, ultraviolet rays, aging, and the like. It is known that the decrease in hyaluronic acid in the skin may cause skin malfunction such as a decrease in elasticity of the skin, a decrease in elasticity, and wrinkles, and may be related to abnormal joint function. As a direct cause of the decrease in hyaluronic acid, there are hyaluronidase (hyaluronic acid degrading enzyme) and degradation of hyaluronic acid by ultraviolet rays, and a decrease in the amount of hyaluronic acid produced in vivo. For this reason, in order to prevent, suppress, improve or normalize symptoms such as skin malfunctions and joint abnormalities, it is necessary to suppress the decrease in the amount of hyaluronic acid in vivo or to supplement hyaluronic acid.
ヒアルロン酸は、ヒアルロン酸合成酵素により生成される。哺乳類のヒアルロン酸合成酵素としては、Has1、Has2及びHas3が存在することが知られている。特に、Has2はヒトの真皮における主要なヒアルロン酸合成酵素であり、保湿力の高い高分子ヒアルロン酸の合成に関与するといわれている。 Hyaluronic acid is produced by hyaluronic acid synthase. As mammalian hyaluronic acid synthase, Has1, Has2 and Has3 are known to exist. In particular, Has2 is a major hyaluronic acid synthase in human dermis and is said to be involved in the synthesis of high-molecular hyaluronic acid with high moisturizing power.
ヒアルロン酸合成促進作用を有するものとしては、ヒアルロン酸またはその薬学的に許容される塩(特許文献3)、乳塩基性タンパク質画分及び/又は乳塩基性タンパク質画分分解物(特許文献4)、卵殻膜(特許文献5)等が知られているが、セラミドを含有する組成物によるヒアルロン酸合成促進作用については知られていない。 As what has a hyaluronic acid synthesis promotion effect | action, hyaluronic acid or its pharmaceutically acceptable salt (patent document 3), a milk basic protein fraction, and / or a milk basic protein fraction degradation product (patent document 4) Eggshell membranes (Patent Document 5) are known, but hyaluronic acid synthesis promoting action by a composition containing ceramide is not known.
また、セラミドとヒアルロン酸を含有する化粧料(特許文献6)等も開示されているが、使用感の優れた化粧料を開示するに留まり、セラミドとヒアルロン酸とを併用することによる優れた美容効果については知られていなかった。 In addition, cosmetics containing ceramide and hyaluronic acid (Patent Document 6) and the like are also disclosed, but only cosmetics with excellent usability are disclosed, and excellent beauty by combining ceramide and hyaluronic acid. The effect was not known.
本発明は、セラミド及びヒアルロン酸を含有する、美容組成物、皮膚乾燥予防・改善組成物、皮膚水分蒸散抑制組成物、皮膚保湿組成物を提供することを目的とする。 An object of the present invention is to provide a cosmetic composition, a skin dryness prevention / improving composition, a skin moisture transpiration inhibiting composition, and a skin moisturizing composition containing ceramide and hyaluronic acid.
また、本発明は、セラミドを含有する、ヒアルロン酸合成促進剤を提供することを目的とする。 Another object of the present invention is to provide a hyaluronic acid synthesis accelerator containing ceramide.
本出願人は、上記課題を鑑みて鋭意検討を行った結果、セラミドを含有する組成物が優れたヒアルロン酸合成促進効果を有することを見出し、本発明に至った。また、セラミド及びヒアルロン酸を含有する組成物はさらに優れたヒアルロン酸合成促進効果を有することを見出し、本発明に至った。 As a result of intensive studies in view of the above problems, the present applicant has found that a composition containing ceramide has an excellent hyaluronic acid synthesis promoting effect, and has led to the present invention. Moreover, it discovered that the composition containing a ceramide and hyaluronic acid had the further outstanding hyaluronic acid synthesis promotion effect, and resulted in this invention.
本発明の概要は、以下の通りである。
<1>セラミド及びヒアルロン酸を含有することを特徴とする美容組成物。
<2>セラミド及びヒアルロン酸を含有することを特徴とする皮膚乾燥予防・改善組成物。
<3>セラミド及びヒアルロン酸を含有することを特徴とする皮膚水分蒸散抑制組成物。
<4>セラミド及びヒアルロン酸を含有することを特徴とする皮膚保湿組成物。
<5>前記セラミドが、米由来のセラミドであることを特徴とする<1>〜<4>のいずれか1に記載の組成物。
<6>セラミドを含有することを特徴とするヒアルロン酸合成促進剤。
<7>セラミドを含有することを特徴とするヒアルロン酸合成酵素遺伝子発現促進剤。
<8>ヒアルロン酸合成酵素がHas2である、<7>に記載の遺伝子発現促進剤。
<9>前記セラミドが、米由来のセラミドであることを特徴とする<6>〜<8>のいずれか1に記載の組成物。
<10>セラミド及びヒアルロン酸を含有することを特徴とするヒアルロン酸合成促進剤。
<11>セラミド及びヒアルロン酸を含有することを特徴とするヒアルロン酸合成酵素遺伝子発現促進剤。
<12>ヒアルロン酸合成酵素がHas2である、<11>のいずれかに記載の遺伝子発現促進剤。
<13>前記セラミドが、米由来のセラミドであることを特徴とする<10>〜<12>のいずれか1に記載の組成物。
The outline of the present invention is as follows.
<1> A cosmetic composition comprising ceramide and hyaluronic acid.
<2> A composition for preventing and improving dry skin, comprising ceramide and hyaluronic acid.
<3> A skin moisture transpiration inhibiting composition comprising ceramide and hyaluronic acid.
<4> A skin moisturizing composition comprising ceramide and hyaluronic acid.
<5> The composition according to any one of <1> to <4>, wherein the ceramide is a ceramide derived from rice.
<6> A hyaluronic acid synthesis accelerator characterized by containing ceramide.
<7> Hyaluronic acid synthase gene expression promoter characterized by containing ceramide.
<8> The gene expression promoter according to <7>, wherein the hyaluronic acid synthase is Has2.
<9> The composition according to any one of <6> to <8>, wherein the ceramide is ceramide derived from rice.
<10> A hyaluronic acid synthesis accelerator comprising ceramide and hyaluronic acid.
<11> A hyaluronic acid synthase gene expression promoter characterized by containing ceramide and hyaluronic acid.
<12> The gene expression promoter according to any one of <11>, wherein the hyaluronic acid synthase is Has2.
<13> The composition according to any one of <10> to <12>, wherein the ceramide is ceramide derived from rice.
本発明によれば、セラミド及びヒアルロン酸を含有することにより、ヒアルロン酸の合成を促進することによって、皮膚の水分蒸散が抑制されるため、皮膚の保湿効果を高め、肌の乾燥を防止することができ、優れた美容効果を得ることができる。。また、本発明によれば、セラミドを含有することにより、ヒアルロン酸の合成を促進することができる。 According to the present invention, by containing ceramide and hyaluronic acid, by promoting the synthesis of hyaluronic acid, the moisture transpiration of the skin is suppressed, so that the moisturizing effect of the skin is enhanced and the skin is prevented from drying. And an excellent cosmetic effect can be obtained. . According to the present invention, the synthesis of hyaluronic acid can be promoted by containing ceramide.
以下、本発明の組成物について説明する。なお、本発明は、下記の実施の形態に限定されるものではない。 Hereinafter, the composition of the present invention will be described. In addition, this invention is not limited to the following embodiment.
セラミドは、スフィンゴ脂質の一種であり、スフィンゴシンと脂肪酸がアミド結合した化合物群の総称である。セラミドは、天然又は合成のセラミドが知られており、角質層の機能低下の改善等を目的とした美容用途の他、医薬用途等の様々な用途で用いられている。 Ceramide is a kind of sphingolipid and is a general term for a group of compounds in which sphingosine and a fatty acid are amide-bonded. As ceramides, natural or synthetic ceramides are known, and they are used in various uses such as pharmaceutical uses as well as cosmetic uses for the purpose of improving functional deterioration of the stratum corneum.
本発明の組成物に用いるセラミドは、動物や植物、微生物等の原料を由来としており、それらに破砕・粉砕等の処理を行った加工物を直接用いても良く、また、それらを分離・抽出等又は人工的に合成する等の方法で得たものを用いても良い。原料からのセラミドの抽出・分離方法及び合成方法は特に限定されず、目的に応じて適宜選択することができる。抽出方法としては、例えば、エタノール、水、含水エタノール等の当業者が通常用いる抽出溶媒を加え、必要に応じて加温して抽出する方法等を挙げることができる。また、原料からセラミドを得るための破砕・粉砕処理方法は、特に限定されず、湿式・乾式どちらでも良く、粉砕条件、処理装置も特に限定されず、市販の装置等を適宜使用することができる。使用する装置としては、例えば、高圧ホモジェナイザー、超音波粉砕機、気流式粉砕機、高速回転衝撃粉砕機、ボールミル又はビーズミル等が挙げられる。これらの処理は、加工物の粒径等の物性が好ましい範囲内になるよう、必要に応じて複数回繰り返しても良く、複数の処理を組み合わせても良い。本発明において、セラミドの中でも、植物由来のセラミドであることが好ましく、米由来のセラミドであることが特に好ましい。本発明の組成物に配合されるセラミドの含有量としては、特に制限はなく、目的や形状、使用対象等の様々な条件に応じて、広範囲でその含有量を適宜設定できる。例えば、0.00001〜50質量%、好ましくは0.00005〜30質量%、より好ましくは0.0001〜20質量%の範囲で選択される。 The ceramide used in the composition of the present invention is derived from raw materials such as animals, plants, and microorganisms, and processed products obtained by crushing and pulverizing them may be used directly, or they may be separated and extracted. It is also possible to use the one obtained by a method such as the like or artificial synthesis. The method for extracting / separating ceramide from the raw material and the synthesis method are not particularly limited, and can be appropriately selected according to the purpose. Examples of the extraction method include a method in which an extraction solvent usually used by those skilled in the art, such as ethanol, water, and hydrous ethanol, is added, and the mixture is heated and extracted as necessary. Further, the crushing and pulverizing method for obtaining ceramide from the raw material is not particularly limited, and may be either wet or dry, and the pulverizing conditions and processing apparatus are not particularly limited, and a commercially available apparatus or the like can be used as appropriate. . Examples of the apparatus to be used include a high-pressure homogenizer, an ultrasonic pulverizer, an airflow pulverizer, a high-speed rotational impact pulverizer, a ball mill, or a bead mill. These treatments may be repeated a plurality of times as necessary so that the physical properties such as the particle diameter of the processed product are within a preferable range, or a plurality of treatments may be combined. In the present invention, among ceramides, ceramides derived from plants are preferable, and ceramides derived from rice are particularly preferable. There is no restriction | limiting in particular as content of the ceramide mix | blended with the composition of this invention, According to various conditions, such as an objective, a shape, and a use object, the content can be suitably set in a wide range. For example, it is selected in the range of 0.00001 to 50 mass%, preferably 0.00005 to 30 mass%, more preferably 0.0001 to 20 mass%.
ヒアルロン酸は、グリコサミノグリカン(ムコ多糖)の一種であり、N−アセチルグルコサミンとグルクロン酸の二糖単位が連結した構造をしている。本発明に用いるヒアルロン酸の由来については特に制限されるものではなく、例えば、鶏冠から得られたものであってもよく、また微生物由来のものであってもよく、合成品であってもよい。また、酵素などを用いて加水分解したものを使用しても良い。本発明の組成物中のヒアルロン酸の含有量は、特に制限はなく、目的や形状、使用対象等の様々な条件に応じて、広範囲でその含有量を適宜設定できる。例えば、本発明の組成物に対し、0.00001〜50質量%、好ましくは0.0001〜30質量%、より好ましくは0.0001〜10質量%の範囲で選択される。 Hyaluronic acid is a kind of glycosaminoglycan (mucopolysaccharide) and has a structure in which disaccharide units of N-acetylglucosamine and glucuronic acid are linked. The origin of the hyaluronic acid used in the present invention is not particularly limited. For example, the hyaluronic acid may be obtained from a chicken crown, may be derived from a microorganism, or may be a synthetic product. . Moreover, you may use what hydrolyzed using the enzyme etc. There is no restriction | limiting in particular in content of the hyaluronic acid in the composition of this invention, According to various conditions, such as an objective, a shape, and a use object, the content can be suitably set in a wide range. For example, it is selected in the range of 0.00001 to 50% by mass, preferably 0.0001 to 30% by mass, and more preferably 0.0001 to 10% by mass with respect to the composition of the present invention.
本発明の組成物は、経皮や経口等目的に応じて適宜摂取することができ、その摂取方法、摂取量、摂取回数、摂取時期、及び摂取対象としては、特に制限はされない。また、摂取対象個体の年齢、体重、体質等、様々な要因や目的に応じて適宜選択することができる。 The composition of the present invention can be taken as appropriate according to the purpose such as transcutaneous or oral, and there is no particular limitation on the intake method, intake, number of intakes, intake time, and intake target. Moreover, it can select suitably according to various factors and objectives, such as age of an ingestion individual, a body weight, a constitution.
本発明の組成物には、セラミド、又はセラミド及びヒアルロン酸以外に、その他の成分を含有しても良い。本発明の組成物を経皮吸収組成物とする場合、前記その他の成分としては、例えば;増粘剤、保湿剤、防腐剤、pH調整剤、油脂、香料、着色剤、酸化防止剤、防菌防かび剤、アルコール、非イオン界面活性剤、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤などの界面活性剤、無機塩、滑沢剤、溶剤等を挙げることができる。また、本発明においては、化粧品、外用医薬品、医薬部外品等に用いられる薬剤や植物等を目的に応じ使用することができる。 In addition to ceramide or ceramide and hyaluronic acid, the composition of the present invention may contain other components. When the composition of the present invention is a transdermally absorbable composition, examples of the other components include: a thickener, a moisturizer, an antiseptic, a pH adjuster, an oil and fat, a fragrance, a colorant, an antioxidant, Examples include fungicides, alcohols, nonionic surfactants, anionic surfactants, cationic surfactants, surfactants such as amphoteric surfactants, inorganic salts, lubricants, solvents, and the like. Moreover, in this invention, the chemical | medical agent, plant, etc. which are used for cosmetics, an external medicine, a quasi-drug, etc. can be used according to the objective.
本発明の組成物を経口組成物とする場合、前記のその他の成分としては、例えば、タンパク質、水溶性食物繊維、不溶性食物繊維等の食物繊維、ミネラル類、植物又は植物加工品、藻類、乳酸菌、酵母等の微生物等を配合することができる。更に必要に応じて通常食品分野で用いられる、デキストリン、でんぷん等の糖類、オリゴ糖類、甘味料、酸味料、着色料、増粘剤、光沢剤、賦形剤、ビタミン類、栄養補助剤、結合剤、滑沢剤、安定剤、希釈剤、増量剤、乳化剤、食品添加物、調味料等を挙げることができる。これらその他の成分の含有量は、本発明の組成物の形態等に応じて適宜選択することができる。 When the composition of the present invention is an oral composition, examples of the other components include dietary fibers such as protein, water-soluble dietary fiber, insoluble dietary fiber, minerals, plants or plant processed products, algae, and lactic acid bacteria. Moreover, microorganisms, such as yeast, etc. can be mix | blended. In addition, sugars such as dextrin and starch, oligosaccharides, sweeteners, acidulants, colorants, thickeners, brighteners, excipients, vitamins, nutritional supplements, binding Agents, lubricants, stabilizers, diluents, extenders, emulsifiers, food additives, seasonings and the like. The content of these other components can be appropriately selected according to the form of the composition of the present invention.
本発明の組成物を摂取する際の形状も特に限定されず、経皮吸収組成物とする場合、具体的な形状としては、例えば、化粧水、美容液、乳液、クリーム、軟膏、ローション、オイル、パック等の基礎化粧料;石鹸、クレンジングクリーム、クレンジングローション、クレンジングミルク、洗顔料等の皮膚洗浄料;シャンプー、リンス、トリートメント等の洗髪用化粧料;ヘアクリーム、ヘアスプレー、ヘアトニック、ヘアジェル、ヘアローション、ヘアオイル、ヘアエッセンス、ヘアウォーター、ヘアワックス、ヘアフォーム等の整髪料、育毛・養毛料、1剤式染毛剤や2剤式染毛剤、ヘアカラー等の染毛料、パーマネントウェーブ剤や縮毛矯正剤等のパーマ剤やウエーブ保持剤等の頭髪化粧料;ファンデーション、白粉、おしろい、口紅、頬紅、アイシャドウ、アイライナー、マスカラ、眉墨、まつ毛等のメークアップ化粧料;美爪料等の仕上げ用化粧料;香水類、浴用剤、その他、抗炎症剤や腋臭防止剤、ふけ又はかゆみ予防用毛髪化粧料、脱毛抑制剤、除毛剤、髭剃り用剤、日焼け止め剤、にきび予防乃至改善剤、油性肌用化粧料、衛生用品、衛生綿類、ウエットティシュ等が挙げられる。尚、本発明の組成物は歯磨剤、マウスウォッシュ等の口腔用組成物としても良い。また、経口組成物とする場合、具体的な形状としては、例えば、粉や顆粒、細粒等の粉末状、タブレット(チュアブル)状、球状、カプセル状、カプレット状、液状等の形状が挙げられる。尚、カプセル状の経口組成物は、ソフトカプセル及びハードカプセルが含まれる。経口組成物とする場合は粉や顆粒、細粒等の粉末状が好ましく、特に、粉末飲料とすることにより、セラミド及びヒアルロン酸の加工が容易であり、組成物としての安定性にも優れるとともに、カプセルや錠剤等と異なり1度に多くの組成物を摂取することができるので好ましい。 The shape at the time of ingesting the composition of the present invention is not particularly limited, and when it is a percutaneous absorption composition, examples of the specific shape include skin lotion, serum, milky lotion, cream, ointment, lotion, oil. Basic cosmetics such as packs; soaps, cleansing creams, cleansing lotions, cleansing milk, facial cleansers, etc .; shampoos, rinses, treatments, etc .; hair creams, hair sprays, hair tonics, hair gels Hair lotion, hair oil, hair essence, hair water, hair wax, hair foam and other hair conditioners, hair growth and hair nourishing agents, one-part hair dyes and two-part hair dyes, hair color and other hair dyes, permanent wave agents Hair care cosmetics such as permanent agents such as hair straighteners and hair retention agents; foundations, white powder, white lipsticks, lipsticks, Makeup cosmetics such as crimson, eyeshadow, eyeliner, mascara, eyebrows, eyelashes, etc .; cosmetics for finishing such as beauty nails; Hair cosmetics, hair loss inhibitors, hair removal agents, shaving agents, sunscreen agents, acne preventing or improving agents, oily skin cosmetics, hygiene products, sanitary cotton, wet tissue and the like. The composition of the present invention may be a composition for oral cavity such as dentifrice and mouthwash. In the case of an oral composition, specific shapes include, for example, powders such as powders, granules, and fine particles, tablets (chewable), spheres, capsules, caplets, liquids, and the like. . The capsule oral composition includes soft capsules and hard capsules. In the case of an oral composition, powders such as powders, granules, and fine granules are preferred. In particular, by making a powder beverage, the processing of ceramide and hyaluronic acid is easy, and the stability as a composition is excellent. Unlike capsules and tablets, it is preferable because many compositions can be taken at once.
本発明の組成物における、セラミドとヒアルロン酸の配合比(重量比)は特に限定されず、目的や使用対象等の条件に応じて適宜設定でき、セラミド:ヒアルロン酸=1:0.01〜1000、好ましくは1:0.05〜500より好ましくは1:0.1〜100が選択される。 The compounding ratio (weight ratio) of ceramide and hyaluronic acid in the composition of the present invention is not particularly limited, and can be set as appropriate according to the conditions such as the purpose and the object of use, and ceramide: hyaluronic acid = 1: 0.01 to 1000. The ratio is preferably selected from 1: 0.05 to 500, more preferably from 1: 0.1 to 100.
以下、本発明を実施例により具体的に説明する。なお、本発明はこれらの実施例に限定されるものではない。 Hereinafter, the present invention will be specifically described by way of examples. The present invention is not limited to these examples.
<ヒアルロン酸合成酵素遺伝子発現促進作用>
下記表1に記載の被験物質を用いて、ヒアルロン酸合成酵素であるHas2の遺伝子発現促進作用を確認した。なお、セラミドは米由来のセラミドを使用した。
<Hyaluronic acid synthase gene expression promoting action>
Using the test substances shown in Table 1 below, the gene expression promoting action of Has2, a hyaluronic acid synthase, was confirmed. The ceramide used was ceramide derived from rice.
10%FBS−DMEM培地を用いて、正常ヒト皮膚繊維芽細胞(Fibrocell社製、製品番号KF−4109)を37℃、5%CO2の条件下にてインキュベーター内で培養した。トリプシン−EDTA処理により浮遊させた細胞を、コラーゲンコートした24well plateに、5.0×104cells/wellとなるように500μLずつ播種し、37℃、5%CO2の条件下にてインキュベーター内で24時間培養した。培養後、培地を除去し、被験物質含有培地を500μL添加し、37度、5%CO2の条件下にてインキュベーター内で24時間培養した。培養後、培養上清を除去し、PBS 500μL/wellを用いて2回洗浄した後、RNA抽出キット(RNeasy mini kit:QIAGEN社製)を用い細胞からRNAを回収し、RNAを逆転写反応キット(Quantitect Reverse Transcription Kit:QIAGEN社製)を用いてcDNAを合成した。得られたcDNAを10倍希釈し、得られたcDNAを用いて、ヒアルロン酸合成酵素であるHas2のmRNA発現量を測定した。mRNAの発現量は、被験物質を含まない培地のmRNA発現量に対する比として、以下の計算式から算出した。
発現量=(被験物質を含む培地のmRNA発現量)/(被験物質を含まない培地のmRNA発現量)
Normal human skin fibroblasts (manufactured by Fibrocell, product number KF-4109) were cultured in an incubator under conditions of 37 ° C. and 5% CO 2 using 10% FBS-DMEM medium. Cells suspended by trypsin-EDTA treatment are seeded in a collagen-coated 24-well plate at 500 × L so as to be 5.0 × 10 4 cells / well, and in an incubator under conditions of 37 ° C. and 5% CO 2 . For 24 hours. After the culture, the medium was removed, 500 μL of the test substance-containing medium was added, and the cells were cultured in an incubator for 24 hours under conditions of 37 ° C. and 5% CO 2 . After culturing, the culture supernatant is removed, washed twice with 500 μL / well of PBS, RNA is collected from the cells using an RNA extraction kit (RNeasy mini kit: QIAGEN), and the RNA is reverse transcription reaction kit CDNA was synthesized using (Quantitative Reverse Transcription Kit: QIAGEN). The obtained cDNA was diluted 10 times, and the mRNA expression level of Has2 which is a hyaluronic acid synthase was measured using the obtained cDNA. The expression level of mRNA was calculated from the following calculation formula as a ratio to the expression level of mRNA in the medium not containing the test substance.
Expression level = (mRNA expression level in medium containing test substance) / (mRNA expression level in medium not containing test substance)
図1より、被験物質としてセラミドのみを使用した実施例1〜3では、Has2の遺伝子発現量は1.290〜1.548であり、コントロールと比較して高いHas2の遺伝子発現促進作用が得られることがわかった。一方、Has2の遺伝子発現促進作用が知られているヒアルロン酸を使用した比較例1〜2では、1.039〜1.110であり、Has2の遺伝子発現促進作用は、コントロールよりは高いものの、実施例1〜3と比較して低いことがわかった。また、図2、3より、セラミドとヒアルロン酸を併用した実施例4、5は、ヒアルロン酸とセラミドの合計量と同量のヒアルロン酸を使用した場合(比較例1、2)と比較して、高いHas2の遺伝子発現促進作用が得られるのみでなく、ヒアルロン酸とセラミドの合計量と同量のセラミドを使用した場合(実施例2、3)と比較してもさらに高いHas2の遺伝子発現促進作用が得られることがわかった。 As shown in FIG. 1, in Examples 1 to 3 in which only ceramide is used as a test substance, the expression level of Has2 is 1.290 to 1.548, and a higher Has2 gene expression promoting effect is obtained compared to the control. I understood it. On the other hand, in Comparative Examples 1 and 2 using hyaluronic acid, which has a known gene expression promoting action of Has2, 1.039 to 1.110. Although the gene expression promoting action of Has2 is higher than the control, It turned out that it is low compared with Examples 1-3. Moreover, from FIGS. 2 and 3, Examples 4 and 5 using ceramide and hyaluronic acid in combination are compared with the case of using the same amount of hyaluronic acid as the total amount of hyaluronic acid and ceramide (Comparative Examples 1 and 2). Not only can a high Has2 gene expression promoting effect be obtained, but also a higher Has2 gene expression promotion compared to the case where ceramide is used in the same amount as the total amount of hyaluronic acid and ceramide (Examples 2 and 3). It was found that the effect can be obtained.
以上のことから、セラミドは単独であってもヒアルロン酸と比較して少量でHas2の遺伝子発現を促進し、さらにセラミドとヒアルロン酸を組み合わせることで、Has2の遺伝子発現を相乗的に促進することが確認された。これにより、セラミドを含有する本願発明のヒアルロン酸合成促進剤は、優れたHas2の遺伝子発現促進作用を有するものであり、また、セラミド及びヒアルロン酸を含む本発明の組成物は、優れたHas2の遺伝子発現促進作用を有し、ヒアルロン酸の合成を促進することによって、皮膚の水分蒸散が抑制されるため、皮膚の保湿効果を高め、肌の乾燥を防止することができ、優れた美容効果を得ることができる。 From the above, ceramide can promote Has2 gene expression in a small amount as compared with hyaluronic acid even when used alone, and further, by combining ceramide and hyaluronic acid, it can synergistically promote Has2 gene expression. confirmed. Thereby, the hyaluronic acid synthesis promoter of the present invention containing ceramide has excellent Has2 gene expression promoting action, and the composition of the present invention containing ceramide and hyaluronic acid has excellent Has2. By promoting the synthesis of hyaluronic acid, it suppresses the moisture transpiration of the skin by enhancing the synthesis of hyaluronic acid, thereby enhancing the skin moisturizing effect and preventing the skin from drying out, resulting in an excellent cosmetic effect Can be obtained.
本発明によれば、Has2の遺伝子発現が促進され、ヒアルロン酸の合成を促進することができ、皮膚の保湿効果を高め、肌の乾燥を防止することがでるため、美容組成物、皮膚乾燥予防・改善組成物、皮膚水分蒸散抑制組成物、皮膚保湿組成物として使用することができる。 According to the present invention, the expression of Has2 is promoted, the synthesis of hyaluronic acid can be promoted, the skin moisturizing effect is enhanced, and the skin is prevented from being dried. -It can be used as an improvement composition, a skin moisture transpiration suppression composition, and a skin moisturizing composition.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015229214A JP6089163B1 (en) | 2015-11-24 | 2015-11-24 | Beauty composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015229214A JP6089163B1 (en) | 2015-11-24 | 2015-11-24 | Beauty composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP6089163B1 true JP6089163B1 (en) | 2017-03-08 |
JP2017095399A JP2017095399A (en) | 2017-06-01 |
Family
ID=58261771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015229214A Active JP6089163B1 (en) | 2015-11-24 | 2015-11-24 | Beauty composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6089163B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115381738A (en) * | 2022-08-04 | 2022-11-25 | 苏州姑苏欣颜魅丽医疗美容诊所有限公司 | A kind of facial skin repair nutrient solution and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001010946A (en) * | 1999-07-02 | 2001-01-16 | Fancl Corp | Skin cosmetic |
JP2004099564A (en) * | 2002-09-12 | 2004-04-02 | Nikko Chemical Co Ltd | Humectant cosmetic |
-
2015
- 2015-11-24 JP JP2015229214A patent/JP6089163B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001010946A (en) * | 1999-07-02 | 2001-01-16 | Fancl Corp | Skin cosmetic |
JP2004099564A (en) * | 2002-09-12 | 2004-04-02 | Nikko Chemical Co Ltd | Humectant cosmetic |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115381738A (en) * | 2022-08-04 | 2022-11-25 | 苏州姑苏欣颜魅丽医疗美容诊所有限公司 | A kind of facial skin repair nutrient solution and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2017095399A (en) | 2017-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2332520B1 (en) | Lactobacillus paracasei for treating age spots and / or melasma | |
JP5996156B2 (en) | Gene expression promoter for skin beautification, moisturizing composition and skin beautifying composition using the same | |
JPWO2004016236A1 (en) | Cosmetics | |
JP2004203811A (en) | Cosmetic | |
JP5952256B2 (en) | Beauty composition | |
JP2008013565A (en) | Cosmetic method for limiting formation of hollowing of face | |
JP6910751B2 (en) | Moisturizers, anti-inflammatory agents, antioxidants, skin turnover improvers, cell activators and whitening agents | |
JP6089163B1 (en) | Beauty composition | |
KR101841118B1 (en) | Composition for skin external application comprising extract of scenedesmus sp. | |
JP2015160821A (en) | Whitening composition and cosmetic | |
JP5888563B2 (en) | Moisturizer, rough skin improving agent, stratum corneum moisture increasing agent, blood flow improving agent and skin dullness, bear or gloss improving agent | |
JP5926506B2 (en) | Method for producing collagen production promoter, method for producing MMP-1 inhibitor, and method for producing external composition for skin | |
WO2022168939A1 (en) | Ceramide synthase gene expression promoting agent, skin improving agent, functional food for skin improvement, cosmetic, and usage method for dipeptide | |
JP2011241188A (en) | Epidermal keratinization-normalizing agent, external preparation for skin containing the epidermal keratinization-normalizing agent, external preparation for normalizing epidermis, cosmetic, cosmetic for normalizing epidermis, unregulated drug and unregulated drug for normalizing epidermis | |
JP2022031140A (en) | External preparation for skin | |
JP2023008377A (en) | Enzyme-treated material of aralia elata or its extract | |
JP2021172593A (en) | External skin preparation | |
JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
JP6330119B2 (en) | Beauty composition | |
KR101814537B1 (en) | A skin topical composition comprising the bio-cellulose powder for reducing and preventing cellulite | |
KR101814538B1 (en) | A cosmentic composition comprising the bio-cellulose powder for reducing and preventing cellulite | |
WO1999009945A1 (en) | Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology | |
JP7330475B2 (en) | Oral composition and external skin composition | |
JP2011251915A (en) | Cell activator | |
JP5571940B2 (en) | Topical skin preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160613 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6089163 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |